Marshall Wace North America’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-89,932
Closed -$1.6M 1355
2020
Q3
$1.6M Sell
89,932
-9,740
-10% -$177K 0.01% 656
2020
Q2
$1.71M Buy
99,672
+94,311
+1,759% +$1.65M 0.01% 627
2020
Q1
$79K Buy
+5,361
New +$106K ﹤0.01% 1027
2019
Q4
Sell
-26,911
Closed -$632K 1335
2019
Q3
$632K Buy
+26,911
New +$632K ﹤0.01% 772
2019
Q1
Sell
-61,202
Closed -$1.13M 1619
2018
Q4
$1.13M Buy
+61,202
New +$1.14M 0.01% 586
2018
Q3
Sell
-259,906
Closed -$4.34M 997
2018
Q2
$4.34M Buy
259,906
+41,450
+19% +$623K 0.02% 550
2018
Q1
$2.93M Buy
218,456
+23,596
+12% +$349K 0.01% 706
2017
Q4
$3.27M Buy
+194,860
New +$3.6M 0.02% 697

Other funds holding CTRE

Marshall Wace North America's CTRE Position: Q4 2020 in Review

Marshall Wace North America sold out of CareTrust REIT (CTRE) in Q4 2020, closing a stake of 89,932 shares — an estimated $1.6M sold.

Marshall Wace North America first reported a position in CTRE in Q4 2017 and held it in 8 quarters. The position peaked at $4.34M in Q2 2018. 245 funds tracked by Wall St. Rank hold CTRE as of Q4 2020.

  • Marshall Wace North America reported no remaining CareTrust REIT position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 89,932 CareTrust REIT shares in Q4 2020, an estimated $1.6M.
  • Marshall Wace North America first reported a position in CareTrust REIT in Q4 2017 and held it in 8 quarters.
  • Marshall Wace North America's CareTrust REIT position peaked at $4.34M in Q2 2018.
  • 245 funds tracked by Wall St. Rank held CareTrust REIT as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.